Search Results

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Sarah Cannon Research Institute
Feb 10, 2024, 15:51 | Drugs
Vivek Subbiah: Pleased to share my thoughts on Lurbinecredin data in small cell lung cancer
Vivek Subbiah shared a post on LinkedIn: “Pleased to share my thoughts on Lurbinecredin data…
Feb 9, 2024, 15:42 | Blog
Vivek Subbiah: This is the equity gap – and it’s costing lives
Vivek Subbiah shared a post on X/Twitter: "Half the world’s population lacks access to the full…
Feb 7, 2024, 06:33 | Opinion
Vivek Subbiah: Sunday Motivation to Explore innovative strategies and collaborations to break barriers
Vivek Subbiah shared a post on Twitter/X: "Today is World Cancer Day. 'Not everything that…
Feb 5, 2024, 11:19 | Insight
Vivek Subbiah: When the New England Journal of Medicine publishes a Phase 1 study in any field, you know it's a game-changer
Vivek Subbiah shared on LinkedIn: ''When the New England Journal of Medicine publishes a Phase 1…
Jan 30, 2024, 16:31 | Insight
Erika Hamilton: This is what drove the recommendations for colonoscopy to start at 45, not 50 like it used to be
Erika Hamilton recently shared a post by Samu Shiva, Physician Lead of Lifestyle Medicine and…
Jan 29, 2024, 14:31 | Blog
Erika Hamilton: An update in high risk HR+ bcsm
Erika Hamilton shared a post on LinkedIn: “Need a little bit of CME or want…
Jan 25, 2024, 08:51 | Insight
Vivek Subbiah: Tissue Agnostic Precision Medicine in Primary brain tumors like glioblastoma?
Vivek Subbiah shared on LinkedIn: "Hot off the press. What is the impact of Tissue Agnostic…
Jan 24, 2024, 16:55 | Blog
Vivek Subbiah: Meet the amazing Dr. Pamela Kunz, the new Editor of JCO Oncology Advances!
Vivek Subbiah shared a post on X/Twitter: "Please meet the amazing Dr. Pamela Kunz, the new…
Jan 23, 2024, 18:53 | Insight
Ishwaria Subbiah: What motivates patients to use Telehealth...?
Ishwaria Subbiah shared on X: A "What motivates patients to use telehealth? 1 reason was…
Jan 22, 2024, 14:19 | Blog
Vivek Subbiah: 'Was great to partner with her and the team on the Selpercatinib RET fusion tissue agnostic approval
Vivek Subbiah recently shared on X/Twitter: "So nice to catch up with the terrific Dr.…
All: 445 Posts: 331 - 340
Special Coverage